FindArticles > AORN Journal > April, 2003 > Article > Print friendly
Perioperative care of the patient with morbid obesity - Home Study Program
Paula GralingThe article "Perioperative care of the patient with morbid obesity" is the basis for this AORN Journal independent study. The behavioral objectives and examination for this program were prepared by Rebecca Holm, RN, MSN, CNOR, clinical editor, with consultation from Susan Bakewell, RN, MS, education program professional, Center for Perioperative Education.
A minimum score of 70% on the multiple-choice examination is necessary to earn 4.6 contact hours for this independent study. Participants receive feedback on incorrect answers. Each applicant who successfully completes this study will receive a certificate of completion. The deadline for submitting this study is April 30, 2006.
Send the completed application form, multiple-choice examination, learner evaluation, and appropriate fee to
AORN Customer Service c/o Home Study Program 2170 S Parker Rd, Suite 300 Denver, CO 80231-5711 or fax the information with a credit card number to (303) 750-3212.
BEHAVIORAL OBJECTIVES
After reading and studying the article on perioperative care of the patient with morbid obesity, the nurse will be able to
(1) describe overnutrition,
(2) compare medical and surgical treatment options for patients with morbid obesity,
(3) define nursing considerations of caring for a patient undergoing surgery for morbid obesity,
(4) differentiate between the types of surgical procedures available to treat morbid obesity, and
(5) describe the postoperative course of a patient after having undergone surgical treatment for morbid obesity.
This program meets criteria for CNOR and CRNFA recertification, as well as other continuing education requirements.
Obesity is the underlying pathogenesis of a number of disease processes that are among the top causes of mortality in industrialized societies. Recently, it has been called an epidemic. (1) In the United States, more than 60% of adults are overweight. (2) Obesity differs greatly from morbid obesity. Although obesity and morbid obesity share numerous etiological factors (eg, genetic, environmental, psychosocial, economic), accepted treatment, options differ. Obesity deserves attention and treatment to prevent potential complications. Morbid obesity, however, requires urgent and definitive correction to treat both current and possible future complications and to help prevent a probable shortened lifespan. Currently, therapy for obesity and obesity-related medical conditions costs nearly $1 trillion dollars per decade in the United States alone. (3)
CLASSIFICATIONS OF OVERNUTRITION
States of overnutrition are classified based on body mass index (BMI). This is calculated by dividing a person's weight in kilograms by his or her height in meters squared. Table 1 provides a simplified version of the categories of overnutrition as described by the American Society of Bariatric Surgery (ASBS) and the National Institutes of Health (NIH). (4)
Using BMI as a measure of obesity can be misleading for very muscular people or people with little to no central or abdominal fat. This problem, however, is limited to people with BMIs less than 35. When a person reaches a BMI greater than 35, measurements such as waist to hip ratio and sagittal abdominal diameter become less important. (5) Patients are considered candidates for surgical treatment if they previously failed at medical weight loss attempts and are currently severely obese (ie, BMI > 35) with one or more associated comorbidities or morbidly obese (ie, BMI > 40) with or without comorbidities.
Effects of obesity on body systems. Obesity adversely affects almost all body systems and has been associated with increased risk for a number of malignancies. Table 2 lists those conditions and comorbidities that occur more frequently in people who are obese. This clearly supports the justification that care providers should aggressively treat morbid obesity.
COMPARISON OF MEDICAL VERSUS SURGICAL TREATMENT
Few people who are obese have benefited from medical attempts at excess body weight loss. Medical weight loss for people who are morbidly obese has a 95% failure rate and is extremely unlikely to provide sustained results, reduction of morbidity, or improved survival. Generally, it is accepted that nonsurgical approaches to weight loss for a person who is morbidly obese consistently are unsuccessful. No intervention, other than surgery, has provided any meaningful long-term success. This includes dieting, exercise regimens, psychotherapy, or prescription medications. The consensus, therefore, is that for a person who is morbidly obese, surgery is the only known effective treatment. (6)
Success rate. Almost all available surgical interventions result in an approximately 70% excess body weight loss during the first year. (7) Rather than facing a 95% failure rate for nonsurgical excess body weight loss interventions, the patient can be offered a range of surgical interventions that offer greater than 90% long-term success when using 35% excess body weight loss as the cutoff for success. When using 50% excess body weight loss as the cutoff, the success rate still is better than 70%, even for purely restrictive procedures. With bypass procedures and biliopancreatic diversion, success is even greater.
Complications. The international registry of bariatric surgeries provides data regarding surgical mortality and complications. Statistics demonstrate an overall surgical mortality of 0.17% for patients undergoing bariatric surgery and a complication rate of only 8.5%. (8) Considering patients' preexisting conditions and the risks these patients automatically bring with them to the OR, these statistics represent very low numbers, suggesting that surgical intervention not only is safe but also much safer than lack of intervention. Failure to intervene surgically for these patients undoubtedly results in promulgation of their comorbidities with eventual morbidity and early mortality.
For these reasons, people who are morbidly obese are candidates for surgical intervention. These surgical interventions have low morbidity and mortality and provide a significant and sustained excess body weight loss with reduction of comorbidity rates and improvement in both survival and quality of life for the patient.
SURGICAL APPROACHES TO THE TREATMENT OF MORBID OBESITY
At Inova Fairfax Hospital, Falls Church, Va, the approach to surgical treatment of morbid obesity is patient centered; therefore, no particular weight loss procedure is preferred in comparison to another. A person who is morbidly obese has the right to choose between reasonably equal treatment options. All procedures currently available in the United States and generally accepted in the bariatric surgical community are offered to patients seeking primary treatment for their condition. Many patients are extensively self-educated about their condition and the available options and present with the decision already made regarding the specific procedure desired. Others are unsure at the time of presentation and have done little research on their own to learn about their options. Regardless of presentation, staff members educate patients extensively regarding the history of bariatric surgical procedures and the evolution of procedures as a result of outcomes and complications. Patients are informed about procedures currently available in the United States and procedures or devices not available in the United States. Each surgical option is analyzed carefully, and pros, cons, risks, and benefits are discussed in light of short- and long-term results, weight loss, vitamin and malnutrition risks, and early and late complication rates. Patients are told that the decision primarily is theirs to make, but that the decision should be based on
* their specific physiology,
* their personal and health goals,
* a sound understanding of their eating behaviors,
* the etiology of their obesity (ie, source of excess caloric intake),
* their risk tolerance, and
* their ability to tolerate or accept the consequences or side effects of the particular procedures contemplated.
The preoperative educational process involves a full variety of medical personnel, including the patient's surgeon, a perioperative nurse, an anesthesia care provider, a dietician, and a psychologist. The surgeon oversees the process, which generally is in the form of a two-hour presentation followed by a question and answer session. Immediately after this educational and information-gathering session, the patient attends a support group meeting where he or she is able to interact with patients who have undergone a number of different procedures. At the meeting, the preoperative patient has the opportunity to discuss particular concerns. Only after this process is complete is the patient actually given an appointment to see the surgeon for a physical examination. After the patient has been examined by the surgeon, he or she undergoes specific preoperative testing, and then the surgery is scheduled. This allows the patient ample opportunity to contemplate his or her options and to give truly informed consent.
CALORIC INTAKE
The concept of weight balance or caloric equilibrium is based on the concept of basal metabolic rate, which says that each individual has a certain daily caloric need that will result in neither weight gain (ie, anabolism) nor weight loss (ie, catabolism). For most people, this is about 1,800 calories per day; however, for some it is less, and for others it is more.
The simplified basics of weight balance. Patients who have gained excess body weight have done so by consuming more calories than their body needs on a daily basis for a sustained period of time. If weight gain is ongoing, then excessive intake is ongoing. Weight loss requires that intake or absorption of intake be reduced below metabolic need on a daily basis for a sustained period of time. This process achieves balance when the patient's total body size requires fewer calories for maintenance, and the patient is capable of consuming and absorbing an adequate quantity and quality of nutrients postoperatively. Weight loss, therefore, stops when this equilibrium is achieved.
Reducing intake. How then can the caloric intake of a patient be reduced? The best approach is to determine where the excess calories are coming from and eliminate (ie, restrict) that source or prevent that source of excess calories from being absorbed. To target these sources, patients' excess caloric intake sources are categorized. These excesses are classified as
* bloating--overeating or eating large meals;
* choosing--choosing the wrong foods at each meal (eg, high fat, fried, high carbohydrate, low fiber);
* grazing--constant snacking during the day and between meals or at night; and
* sweeting--frequent ingestion of high calorie simple sugar-containing foods, drinks, or shakes.
Patients are asked to classify themselves to determine where their excess calories come from. If a patient reports that currently he or she does not consume excess calories, then the patient is asked where the excess calories came from in the past. Most patients can classify themselves into one or two categories. Patients who report that they have had stable weight for more than one year likely truly have modified their diets to reach balance. These patients are classified as. normal to low metabolizers, depending on their reported caloric intake.
The best judge of a patient's need is the patient. The only limiting factor is the patient's knowledge base. When the patient determines the source of his or her excess calories, the appropriate procedure can be chosen. This process is accomplished cooperatively with the patient and his or her health care providers, who consider all factors contributing to the decision, including the patient's weight loss goals, short and long-term risk tolerance, and side-effect tolerance.
PATIENT SELECTION
The most important factor in achieving success in bariatric surgery is patient selection and intervention selection. Most patients who present for evaluation for bariatric surgical procedures are self-referred, determined to achieve change, and willing to make personal lifelong sacrifices to achieve their goals. Candidates who are not self-referred generally are reluctant, uncertain, and attached to certain eating behaviors (eg, binge eating, specific food addiction). These patients need to be counseled extensively before undergoing surgery. Table 3 provides a glossary of terms common to many bariatric surgical procedures.
Anatomical and historical considerations. Figure 1 shows the normal anatomy of the gastrointestinal tract. The esophagus is the first passageway into the stomach. Historically, interventions above or at the level of the esophagus have not been effective for the treatment of morbid obesity. For example, wiring the teeth shut is ineffective because patients' nutritional source becomes high-calorie liquids and shakes. Patients rapidly reach their homeostatic or baseline level of nutritional intake and, therefore, do not lose weight.
[FIGURE 1 OMITTED]
Some antireflux devices used in the past demonstrated that obstructive devices on the esophagus were fraught with complications, such as erosion and esophageal dilation. These devices, therefore, became a nonviable option.
The esophagogastric junction (EGJ) and its physiological function to relax for food passage and tighten to prevent reflux is important. In patients with significant reflux disease, certain procedures should be avoided: The fundus of the stomach has a thin wall and a great propensity to stretch, so this portion of the stomach should not be used in the formation of a pouch. The body of the stomach produces acid and has a muscular digestive function for mixing chyme, so it is not ideal for use in formation of a pouch.
The lesser curvature of the stomach is the thicker walled portion of the stomach that has less propensity to stretch and is more fixed in position. The pylorus (ie, stomach outlet) is important in
* regulating the output of the stomach to properly limit acid output into the duodenum,
* controlling chyme and other fluid output from the stomach, and
* preventing bile reflux between meals.
Denervation of the pylorus results in spasm and obstruction. Disabling (ie, through pyloroplasty or pyloromyotomy) or bypassing the valve results in dumping syndrome because of unregulated emptying of high solute concentration liquids, specifically sweets, into the small bowel. Dumping syndrome is defined as a symptom complex usually occurring with sweet or sugar intake after a procedure that obliterates or bypasses the function of the pyloric sphincter. Symptoms can include faintness, palpitations, nausea vomiting, low blood pressure, sweating, mild to explosive diarrhea, or pain.
The antrum (ie, lower one-third of the stomach) is important for two main reasons. First, it harbors G cells that secrete gastrin, which is a paracrine and endocrine hormone that stimulates acid production. This is important when considering the larger pouch of the biliopancreatic diversion procedure without duodenal switch in which the endocrine gastrin effects can increase pouch acid production and increase the rate of ulceration if the antrum is not removed. This is why a distal gastrectomy is recommended with larger pouch procedures, such as biliopancreatic diversion without duodenal switch. The acid also is important when considering the duodenal switch procedure (ie, longitudinal or lateral gastrectomy with preservation of the pylorus and anastomosis to the duodenum) in which preservation of antral acidification helps convert dietary iron to its absorbable oxidized ferric form. Parietal cells in the antrum also produce an intrinsic factor, a protein necessary for [B.sub.12] absorption in the ileum. The duodenum is important in the secretion of a number of hormones, including secretin, cholecystokinin, and enteroglucagon. Leaving the duodenum in the digestive food channel is believed to allow for more normal gastrointestinal hormonal response to meals, which helps provide an improved physiological response to meals and improved satisfaction.
The bile duct, main pancreatic duct, and accessory pancreatic ducts illustrate the anatomical and surgical hazards associated with performance of the duodenal switch procedure and allow for an understanding of its mechanism. Portions of the small bowel are shown with their approximate unstretched lengths to allow for understanding the sections of intestinal tract used in various parts of the surgical procedures.
NURSING CONSIDERATIONS
It is important that perioperative team members be familiar with the needs of a patient undergoing bariatric surgery. Caregivers should consider the patient's physical and psychological needs. Appropriately sized gowns and blood pressure cuffs, as well as stretchers, must be readily available so that the patient is made to feel welcome and not embarrassed by the lack of attention to his or her size requirements. Additionally, specific education regarding psychological needs of patients who are morbidly obese is provided to preoperative personnel, including the registration clerk and holding area receptionist. Patients often view this day as the first day of the rest of their lives. Unsolicited or inappropriate comments can spoil the experience for them, much the same as spoiling a wedding day. Comments such as "you don't look like you need this surgery" or "oh, but you really do carry your weight well" may be offered as compliments but can be perceived negatively by the patient. The patient's family members already may have accused the patient of taking the easy way out by having surgery. Inappropriate comments may. be reminiscent of past accusations of lack of willpower or effort.
Preoperative phase. The patient usually is admitted to the hospital on the same day of surgery. He or she is escorted directly from the registration area to the preoperative holding area. In the preoperative holding area, the preoperative nurse asks the patient to change into a patient gown and wait on a stretcher for consult with perioperative team members. The preoperative nurse completes a patient assessment of vital signs, reviews laboratory work for variations in normal values, and reviews the chart for completion of necessary paperwork (eg, signed consent form, surgeon's history and physical examination).
The circulating nurse arrives from the OR to greet the patient in the preoperative holding area. He or she performs a brief assessment of factors affecting positioning, reviews the planned procedure, and gives the patient and family members an opportunity to ask questions. The circulating nurse then develops a care plan specific to this patient and the procedure being performed (Table 4). The patient remains in the preoperative holding area until the anesthesia care provider completes a preoperative assessment, places an IV line, and administers a preoperative dose of antibiotics. When the surgeon arrives and confirms the planned procedure, the anesthesia care provider notifies perioperative nursing team members and transports the patient to the OR.
Intraoperative phase. If at all possible, preoperative sedative medications are kept to a minimum to facilitate patient transfer from the stretcher to the OR bed. When in the room, the patient is assisted with moving to the bed, which has specialized hydraulics and padding to accommodate a patient with morbid obesity. The anesthesia care provider usually elevates the head of the bed to assist with the patient's respiratory effort. Awake positioning is preferred, particularly if the patient has multiple joint limitations.
Positioning. Intraoperative team members work cooperatively to place the patient in the supine position on the bariatric OR bed. The circulating nurse places side bed attachments, if needed, for patients with extra-wide girth. The circulating nurse places a padded footboard on the foot of the bed to prevent the patient from slipping when the bed is placed in reverse Trendelenburg's position.
The anesthesia care provider helps the patient extend his or her arms on arm boards, places padding under bony prominences, and secures the patient's arm with cotton cast padding and hook and loop fastening straps. If the patient is undergoing a duodenal switch procedure, the circulating nurse tucks the patient's left arm at his or her side to facilitate surgeon positioning during measurement of the small bowel limb segments.
The circulating nurse places a urinary catheter. Several assistants may be needed to provide retraction of the panniculus and thighs for access during catheter placement.
The circulating nurse places sequential compression devices on the patient's lower legs and then places a pillow under the patient's knees to reduce back strain. The nurse securely wraps the patient's legs with a soft blanket to support the legs in a comfortable position of thigh adduction with physiological external rotation and to avoid pressure on the lateral aspect of the lower leg and feet.
The circulating nurse places an electrosurgical grounding pad on the patient's left lateral thigh and then places upper and lower temperature-regulating blankets to maintain the patient's body temperature. Finally, the circulating nurse places two sets of safety straps, one across the patient's lower legs and the other across his or her thighs.
Inducing anesthesia. Before induction of anesthesia, the circulating nurse and anesthesia care provider question the patient about his or her comfort to ensure that tissue is not pinched and placement of extremities is comfortable. Anesthetic techniques are the same as for any other abdominal procedure. The anesthesia care provider continuously monitors the patient's vital signs, including pulse, blood pressure, electrocardiogram, pulse oximetry, and end-tidal carbon dioxide. The anesthesia care provider anesthetizes the patient using a balanced technique of IV induction and inhalation maintenance. Nitrous oxide generally is avoided, as with most laparoscopic procedures, because it tends to diffuse into gas-filled organs. This dilates the organs intraoperatively, thereby obstructing the laparoscopic surgical view. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids also are avoided for hematologic and gastric reasons. For example, some NSAIDs, such as IV ketorolac, are avoided because they can cause gastric irritation and slow the healing process of the fresh gastric staple and suture lines. Additionally, routine use of dexamethasone is avoided to prevent gastritis and problems with healing and to avoid confounding factors when evaluating the patient's laboratory results. The circulating nurse ensures that an anesthesia cart specially stocked for management of difficult airways, including a rigid fiberoptic laryngoscope, is available in the room. After intubation, the anesthesia care provider empties the patient's stomach with a nasogastric tube. The anesthesia care provider takes special care to ensure the removal of all esophageal tubes during insertion of sizing tubes, such as bougie dilators.
Prepping and draping. The nurse documents the patient's skin condition and measures used to prevent injury intraoperatively. The circulating nurse performs an abdominal prep, including the skin folds under the panniculus (ie, overhang of abdominal tissue). The circulating nurse ensures that the scrub person has extra draping towels, as needed. Surgical team members perform standard draping for an abdominal incision. The anesthesia care provider places the OR bed in reverse Trendelenburg's position for easy access to the patient's upper stomach. For large patients, surgical team members may need step stools to work within the sterile field.
AVAILABLE PROCEDURES
Numerous surgical procedures are available to treat morbid obesity. These procedures differ in their approach to anatomy and the desired outcome. Weight loss or bariatric surgeries describe a broad group of procedures whose subcategories include purely restrictive (ie, limiting the amount of food intake), gastric bypass, biliopancreatic diversion, purely malabsorptive (ie, reduced calorie and nutrient absorption), and neurostimulatory procedures (Table 5).
Vertical banded gastroplasty (VBG). Vertical banded gastroplasty is a purely restrictive procedure in which a small pouch (eg, approximately 15 mL to 30 mL) and a large liquid reservoir are created. No stomach tissue is removed. It is best suited for patients whose excess caloric intake source is bloating. This procedure often fails with patients who are classified as grazers or whose excess caloric intake source is sweets. It offers a low malnutrition or vitamin deficiency risk (1%), and patients require only one multivitamin injection (MVI) daily. When successful, patients may expect a 60% excess body weight loss. Specific complications include esophagitis, band erosion, or staple line failure. If revision is needed as a result of liver or gastric scarring, an open procedure usually is necessary because the VBG may be difficult to revise (Figure 2).
[FIGURE 2 OMITTED]
Proximal gastric bypass. Proximal gastric bypass is considered a mostly restrictive procedure. Like the VBG, a small pouch is created without removal of stomach tissue. A small 1-cm anastomosis is created with an intestinal bypass using a 100-cm Roux limb, a short biliopancreatic limb, and an approximate 400-cm common channel. The proximal gastric bypass works for patients who are classified as sweeters and bloaters but can be overcome by patients who are classified as grazers. Patients have some dumping syndrome but usually have little acid reflux. When successful, a patient may expect 60% to 65% excess body weight loss. There is a low early failure rate, and 20% to 25% of patients experience a late (ie, after three years) weight gain of 20% to 30%. Specific complications include anastomotic ulcer and stricture and failures that are converted to a distal bypass or duodenal switch. (Figure 3).
[FIGURE 3 OMITTED]
Distal gastric bypass. Distal gastric bypass is a partially restrictive and partially malabsorptive procedure. As with other restrictive procedures, a small pouch is created, and no stomach tissue is removed. The anastomosis is small (ie, 1 cm) with a long Roux limb, short biliopancreatic limb, and 100-cm common channel. The distal bypass generally eliminates reflux but occasionally causes dumping. It is a viable option for patients who are classified as sweeters, grazers, and bloaters but can be overcome by persistent bad eating habits. There is a high malnutrition and vitamin deficiency risk with distal gastric bypass, and patients require 12 MVIs per day. Patients experience a 90% excess body weight loss with a low early failure rate, but there is a possibility of mild weight regain after two years. Specific complications are anastomotic ulcer or stricture, and sometimes revision is needed to correct malabsorption (Figure 4). This procedure generally is discouraged because it carries the highest risk with regard to malnutrition as a result of the small pouch in combination with a short common channel. A duodenal switch procedure is preferable for patients who need malabsorption.
[FIGURE 4 OMITTED]
Vertical gastroplasty with sleeve gastrectomy. The vertical gastroplasty with sleeve gastrectomy is a restrictive procedure usually performed with a duodenal switch. It may be performed alone to reduce perioperative risk in a patient who is extremely morbidly obese with the intent of performing the duodenal switch as a second stage after a 100-lb to 200-lb weight loss. Anatomically, the vertical gastroplasty with gastrectomy leaves a tubular stomach, which preserves some antrum for better iron and [B.sub.12] absorption. It does not change reflux, reduces total acid producing capacity, and preserves the pylorus so there is no dumping syndrome. There is little malnutrition risk, and the patient usually takes one MVI per day. Success of this procedure provides the patient with more than 65% excess body weight loss at one year, although there may be failure with patients who are classified as sweeters and grazers. Specific complications relate to delayed gastric emptying and reflux. The procedure may allow for the increased efficiency of weight loss medications and is easy to convert to a duodenal switch at a later time (Figure 5). It is very easy for patients to consume more than 700 calories per meal if they make poor food choices because of the larger remnant (ie, pouch). For this reason, this procedure, when performed as the only planned procedure, is limited to patients willing to carefully monitor their caloric intake and diet after surgery.
[FIGURE 5 OMITTED]
Biliopancreatic diversion (BPD) with duodenal switch, vertical gastroplasty/sleeve gastrectomy. This procedure was introduced approximately 15 years ago as an alternative to the Scopinaro BPD and has several advantages. Specifically, the procedure depends more on malabsorption than restriction to accomplish weight loss, and this appears to improve the long-term success rate. The absence of a gastro-enteric anastomosis reduces marginal ulcer and stricture risk. Leaving the pylorus functional avoids the dumping syndrome, and antral acidification of iron and flow through the duodenum and antral gastrin secretion improves iron and vitamin [B.sub.12] absorption, thereby almost eliminating the risk of these deficiencies. The procedure generally has been reserved for patients with higher BMIs (ie, greater than 45) but in recent years has been offered to patients with lower BMIs (ie, 35 to 44) with good results and low morbidity. More than 250 laparoscopic duodenal switch procedures have been performed at Inova Fairfax Hospital with no deaths, low morbidity, and excellent weight loss results. The duodenoenteric anastomosis was performed using a laparoscopic handsewn method without leaks in the last consecutive 200 procedures. The procedure is not without its drawbacks, however, and it does have a higher malnutrition risk (ie, 5% to 7%) than proximal bypass. It also has associated side effects of steatorrhea and foul stool and gas, especially with fatty and carbohydrate rich foods. There is a higher incidence of vitamin D and calcium malabsorption, and vitamin A dosing becomes an issue during pregnancy. Patients who choose this procedure generally are very happy with it because the larger meal size is important to them and the absence of dumping syndrome also is relevant. Patients, however, must be compliant with vitamin and protein intake, or malnutrition will develop (Figure 6).
[FIGURE 6 OMITTED]
Adjustable gastric band (AGB). The AGB procedure is ideal for patients who are afraid of highly invasive procedures and want a simple, easily reversible procedure to help with portion control. Patients might say that they like that there is no stomach stapling, removal, or rearrangement. Patients also must desire the adjustability, which allows them to ease into it with progressive needle adjustments, and they cannot mind the needle adjustments. Patients must be willing to comply with sweet and snack avoidance postoperatively to see success (Figure 7).
[FIGURE 7 OMITTED]
Non-FDA approved options. Use of the gastric balloon has been difficult to revive in the United States. A variant of gastric balloon was available in the United States in the 1980s but was banned due to the complication rate. The current version is modified and has lower bleeding or obstruction complication rates; however, the efficacy is short-lived and minimal compared with the better than 50% excess body weight loss seen in other currently used bariatric procedures. It usually is used in Europe as a bridge to weight loss in patients who are morbidly obese.
A modified cardiac pacemaker may be used to reduce appetite by inducing a feeling of satiety. The electrodes are placed in the muscle. Electrical impulses from the device reduce appetite and stimulate the muscles and the nerves on the muscles to contract, which speeds up stomach emptying. The gastric pacemaker still is investigational. Very little literature exists regarding its effectiveness and complications (Figure 8).
[FIGURE 8 OMITTED]
AFTER COMPLETION OF THE PROCEDURE
The surgeon performs an intraoperative endoscopy with pressure insufflation and leak test at the end of the surgical procedure. The surgeon places a drain before closure if the patient had an anastomosis, which facilitates early diagnosis of an anastomotic leak. At the completion of the procedure, the incision is injected with 0.25% bupivicaine to assist with pain management. The anesthesia care provider extubates the patient in the OR, and surgical team members transfer the patient to a bed equipped with specialized padding and sturdy hydraulics. The anesthesia care provider and nurse then transport the patient to the postanesthesia care unit (PACU).
POSTOPERATIVE CARE
The patient spends approximately one hour in the PACU and then is taken to the surgical floor. The patient may be admitted to a critical care unit if he or she is experiencing shortness of breath, needs continuous positive airway pressure, or has complex medical conditions requiring continual observation and care.
Depending on the details of the surgery, patients may awaken with a nasogastric (NG) tube in place. It also may be necessary to perform an x-ray leak test after surgery. This usually is done on the first or second day after surgery, as needed. If it is needed, the patient is taken to the radiology department. The radiology technologist gives the patient clear x-ray contrast medium to sip at specified times during the procedure. The radiologist takes several x-rays as the patient swallows the contrast medium. The technologist prints the x-rays, and the radiologist and surgeon carefully review the results. A decision is made whether to leave the NG tube in place and when to start the patient on a liquid diet. At Inova Fairfax Hospital, the first 50 patients all had postoperative esophagograms. With program maturity and a leak rate of 0%, esophagograms now are used only for a select group of patients.
Each bariatric procedure has its own specific postoperative instructions, which are tailored in detail to the type of procedure. If surgery was performed laparoscopically and the patient is able to tolerate liquids, discharge to home may be accomplished on the same day as surgery. As with any laparoscopic procedure, patients have smaller scars, reduced pain, decreased length of stay, and shorter recovery time compared to open surgery. All patients receive antibiotic coverage, respiratory support (eg, nebulizer, incentive spirometry), patient-controlled analgesia, and sequential compression stockings and enoxaparin sodium to minimize deep vein thrombosis. Table 6 is a sample set of orders for a patient's day of surgery and first postoperative day.
Dietary instructions. For the first two days after surgery, dietary intake is limited to clear liquids. Intake gradually is advanced during the next few days. For example, on days three and four, the diet is advanced according to tolerance. The patient is expected to walk daily and regularly and sit in a chair when not walking. If tolerating liquids well, the patient may advance to a low carbohydrate, full liquid diet as early as the third postoperative day. The patient stays on this diet for two days. Medications must be crushed or opened. Common medications include ursodiol (ie, if gallbladder was not removed), pain medications, lansoprazole, multivitamin with iron, and medications previously prescribed for chronic medical conditions. On the fifth and sixth postoperative day, the diet continues to advance. The patient now should be able to safely begin eating pureed foods, including baby foods, applesauce, blended soft foods, and potted meats. The patient needs to drink constantly to remain hydrated. The patient will not need to supplement with protein powder during these early days. On the sixth and seventh day, the diet progresses to soft foods, including all of the previously mentioned pureed items, all allowed liquids, and soft foods, such as baked white fish without bones, imitation crab meat, hot dogs, canned fruits, and over-cooked vegetables. Hard meats, such as steak, pork, and chicken, are not allowed.
During the second through third weeks, the patient begins a regular food trial period. This includes all previously allowed items plus red meat, chicken, and well-cooked vegetables. This is called a trial period because patients are expected to try only one new item at a time. If adding one new regular food per day, 14 new items have been added by the end of this period. The patient also may begin trying to take whole pills, one at a time, during this period rather than crushing them. (9)
POSTOPERATIVE FOLLOW-UP
The patient is instructed to be as active as possible, walking up to one mile per day by the postoperative office visit. He or she also is instructed to wear an abdominal binder while active. Activity gradually is increased; however, the patient is instructed to avoid heavy lifting for three to six weeks after surgery to allow the incisions to heal solidly. The patient may return to work one week after surgery if he or she underwent a laparoscopic procedure. If the patient underwent an open procedure, he or she may be able to return to work approximately six weeks later.
The patient must keep a record of exactly what and how much he or she eats and drinks at every meal for the first three weeks after surgery. This is the only way the surgeon can determine whether dietary protein intake is adequate. The patient should bring the dietary log to the first postoperative visit. If the patient has diabetes, he or she probably will have reduced or discontinued medicines and must check his or her blood glucose twice daily to determine whether adjustments are necessary. Follow-up appointments are scheduled once per month for the first year, during which the patient's weight is checked. Laboratory work is completed (eg, hemoglobin, albumin, electrolytes, vitamin levels) six months after surgery, or sooner if the patient reports that he or she is eating poorly, to detect any vitamin deficiencies.
Long-term support. A bariatric support group for preoperative and postoperative patients is held once per month by the surgeon. Each week, patients of specific surgical types hold their own support group, which is moderated by a patient. After weight loss, the patient may need to return to the OR for a secondary procedure. Sagging skin in the face, arms, breasts, and abdomen may lead to functional and aesthetic deformities. (10) Skin folds may contribute to problems with hygiene and may cause chronic skin inflammation or infection. The patient may seek consultation with a plastic surgeon for a face lift, mammoplasty, or abdominoplasty for removal of excess skin.
The commitment to the bariatric patient does not end when the immediate perioperative period is complete. Administration of a comprehensive bariatric program encompasses many aspects besides the surgical intervention. A successful program includes nutritional support, psychological support, and availability of practitioners to help with any complications experienced by the patient. More than 500 procedures have been performed since inception of the program in 1999 at Inova Fairfax Hospital. Patients report a 100% satisfaction rate, a decrease in comorbidities, and greater enjoyment of their healthier lifestyle.
Table 1
CLASSIFICATION OF WEIGHT
BODY MASS INDEX (BMI) (1)
BMI * Category
< 18.5 Underweight
18.5 to 24.99 Normal
25 to 26.9 Overweight
27 to 30 Mild obesity
31 to 35 Moderate obesity
36 to 40 Severe obesity
41 to 45 Morbid obesity
> 50 Super obesity
* Measured in kilograms per meter squared
NOTE
(1.) "Clinical guidelines on the identification, evaluation,
and treatment of overweight and obesity in adults,"
National Institutes of Health, http://www.nhlbi.nih.gov
/guidelines/obesity/ob_exsum.pdf (accessed 30 Jan
2003).
Table 2
OBESITY-SPECIFIC COMORBIDITIES (1)
Cardiovascular
Atherosclerotic disease
Congestive heart failure
Hypertension
Varicose veins
Venous insufficiency and stasis
Dermatologic
Cellulitis
Dermatitis
Necrotizing infections
Panniculitis
Endocrine/metabolic
Diabetes mellitus
Glomerulosclerosis and renal failure
Gout
Hyperlipidemia
Gastrointestinal
Abdominal wall hernia
Fatty liver
Gallbladder disease
Gastroesophageal reflux disease
Irritable bowel syndrome
Genitourinary disease
Dysmenorrhea
Hirsuitism
Infertility
Polycystic ovarian disease
Urinary stress incontinence
Malignancies
Breast cancer
Colorectal cancer
Endometrial cancer
Gallbladder cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Uterine cancer
Musculoskeletal
Bone demineralization
Carpel tunnel syndrome
Low back pain
Osteoarthritis
Neuropsychiatric
Depression
Idiopathic intracranial hypertension
Stroke
Ophthalmologic
Cataracts
Glaucoma
Pulmonary
Asthma
Obesity hypoventilation syndrome
Pulmonary hypertension
Sleep apnea
NOTE
(1.) F Pi-Sunyer, "Comorbidities of overweight and obesity: Current
evidence and research issues," Medical Science Sports and Exercise 31
no 11 suppl (November 1999) 602-608.
Table 3
GLOSSARY OF BARIATRIC SURGICAL TERMS
Anastomosis
A newly established connection between two hollow
structures (ie, stomach to intestine, intestine to intestine,
intestine to colon, bile duct to intestine). This can be a
stapled, sewn, or mixed connection. Such connections
can be end to end, end to side, or side to end.
Band
A strip of tissue, mesh, tube, or device that is wrapped
around the stomach, part of the stomach, or pouch that
serves to restrict the outflow of food from one part of the
stomach or the pouch to another part of the stomach or
to an intestinal anastomosis.
Biliopancreatic limb
The segment of small bowel that starts at the second
portion of the duodenum where the bile duct enters the
duodenum and ends when and where it enters into the
Roux limb. This is the bile-carrying limb.
Common channel
The segment of small bowel that starts where the biliopancreatic
limb enters into the Roux limb and ends at
the cecum. This is the segment where complex proteins,
fats, and carbohydrates are best digested.
Pouch
The portion of the stomach that serves as a reservoir for
food immediately after food exits the esophagus.
Roux limb
The segment (ie, limb) of small bowel that first receives
food, starting where food enters it and ending where the
biliopancreatic limb joins it.
Staple line
A row of staples fired into the bowel or stomach by a stapling
device. A staple line can be within an anastomosis,
in a partition, or in a divided bowel end. One staple line
sometimes is incorporated into another or into a fully
hand-sewn anastomosis.
Table 4
NURSING CARE PLAN FOR A PATIENT UNDERGOING SURGERY FOR MORBID OBESITY
Nursing
diagnosis Interventions
Altered nutrition, * Provides instruction to enhance patient's
more than understanding of mechanism for weight loss and
body require- need for nutritional supplements.
ments related
to specific
eating patterns
Risk for anxiety * Determines knowledge level, assesses readiness
related to knowl- to learn, and identifies barriers to
edge deficit and communication.
stress of surgery
* Explains sequence of events and reinforces
teaching about treatment options.
* Provides instruction (ie, verbal, written) for
surgical procedure and discharge based on age
and identified need and ensures availability
of support group interaction.
* Communicates patient concerns to appropriate
surgical team members.
* Helps patient maintain self-esteem by obtaining
appropriately sized items (eg, gowns, wide
stretchers, fitted blood pressure cuff).
* Evaluates response to instruction.
Risk for altered * Assists with endotracheal intubation and
pulmonary ensures availability of difficult airway cart
function related in the OR and continuous positive airway
to morbid pressure machine in the postanesthesia care
obesity and unit.
hypoventilation
* Monitors change in respiratory status.
Risk for acute * Assess patient's pain preoperatively.
or chronic
pain related * Identifies patient's accepted postoperative
to surgical pain threshold.
procedure
* Provides pain management instruction and pain
scale to assess pain control.
* Evaluates patient's response to pain management
interventions.
Risk for * Verifies patient's identity, allergies, NPO
injury related to status, and informed consent.
perioperative
experience * Assesses skin integrity, sensory impairments,
and musculoskeletal status.
* Transfers patient while awake using appropriate
number of assistive personnel, implementing
protective measures to prevent positioning
injury, and maintaining correct body alignment.
* Evaluates for signs and symptoms of injury.
Nursing Interim Outcome
diagnosis outcome criteria statement
Altered nutrition, The patient The patient
more than verbalizes demonstrates
body require- understanding of knowledge of
ments related altered nutrition. nutritional
to specific requirements for
eating patterns selected surgery.
Risk for anxiety The patient The patient
related to knowl- verbalizes demonstrates
edge deficit and * decreased knowledge of
stress of surgery anxiety and an the expected
ability to cope, response to the
* understanding procedure and
of individualized discharge care.
procedure and The patient par-
sequence of ticipates in deci-
events, sions affecting
* that questions his or her plan
have been of care.
answered, and
* expected
outcomes.
Risk for altered The patient The patient's
pulmonary is extubated pulmonary func-
function related within 24 hours tion is consis-
to morbid postoperatively. tent with or
obesity and improved from
hypoventilation baseline levels.
Risk for acute The patient The patient
or chronic demonstrates demonstrates
pain related adequate pain and reports ade-
to surgical management. quate pain con-
procedure trol throughout
the perioperative
period.
Risk for The patient's skin The patient is
injury related to remains smooth free from posi-
perioperative and intact, and tioning injury
experience neuromuscular from extraneous
functions are objects.
maintained or
improved from
baseline.
Table 5
COMPARISON OF THE TYPES OF SURGICAL PROCEDURES TO TREAT MORBID OBESITY
Vertical banded gastroplasty
Features * Small 15-mL to 30-mL pouch
(ie, 500 * Large liquid reservoir
cm un- * No malabsorption
stretched * Fails with sweeters and grazers
total bowel * Best suited for bloaters
length) * May worsen reflux if poor lower eso-
phageal sphincter
* No stomach removed
Weight * When successful, can expect to lose
loss 60% of excess body weight
Malnutrition * Low malnutrition or vitamin deficiency
risk (ie, < 1%)
* Requires 1 multiple vitamin injection
(MVI) daily
Revision * Difficult to revise; however, if a revisior
is necessary as a result of liver or
stomach scarring, it usually requires
an open procedure
Possible * Esophagitis
late * Band erosion
compli- * Staple line failure
cations
Proximal gastric bypass
Features * Small 15-mL to 30-mL
(ie, 500 pouch
cm un- * Mostly restrictive
stretched * Causes dumping syndrome
total bowel * Eliminates acid reflux
length) * Works for sweeters and
bloaters
* Grazers can beat the surgi-
cal procedure
* No stomach removed
* Small 1-cm anastomosis
* 100-cm Roux limb
* Short (ie, 20 cm to 75 cm)
biliopancreatic limb
* 400-cm common channel
Weight * Low early failure rate
loss * 20% to 25% late (ie, two
to three years) weight gain
of 20% to 30%
* When successful, can expect
to lose 60% to 65% of
excess body weight
Malnutrition * Low malnutrition or vitamin
deficiency risk (ie, < 1% to
2%)
* Requires 1 MVI daily
Revision * Failures are converted to dis-
tal bypass or biliopancreatic
diversion with duodenal
switch
Possible * Anastomotic ulcer or stricture
late
compli-
cations
Distal gastric bypass
Features * Small 15-mL to 30-mL
(ie, 500 pouch
cm un- * Partially restrictive
stretched * Partly malabsorptive
total bowel * Can possibly cause
length) dumping syndrome
* Usually eliminates reflux
* Reasonable for sweeters,
grazers, and bloaters
* Can be beaten by persistent
bad habits
* No stomach removed
* Small 1-cm anastomosis
* Long 400-cm Roux limb
* Short (ie, 20 cm to 75 cm)
biliopancreatic limb
* 100-cm common channel
Weight * Low early failure rate
loss * Possible mild weight regain
after two years
* Can expect to lose 90% of
excess body weight
Malnutrition * High malnutrition and vita-
min deficiency risk (ie, 10%
to 20%)
* Requires 12 vitamin tablets
daily
Revision * Sometimes needed to correct
malabsorption
Possible * Anastomotic ulcer or stricture
late
compli-
cations
Vertical gastroplasty with sleeve
gastrectomy
Features * Large 90-mL to 150-mL tubular
(ie, 500 stomach
cm un- * Restrictive
stretched * Does not change acid reflux but
total bowel reduces total acid producing capacity
length) * Fails with sweeters and grazers
* Usually performed with duodenal switch
* Performed alone to reduce risk in
patients who are super morbidly obese
with intent to perform duodenal switch
after 100-lb to 200-lb weight loss
* Sometimes performed in selected
minimally obese patients (ie, < 350
lbs) who wish to minimize bowel sur-
gery risk and are highly motivated,
nongrazers, and nonsweeters
* Preserves some antrum for better iron
and vitamin [B.sub.12] absorption
* Preserves pylorus to prevent dumping
syndrome
* Stomach segment resected and
removed from body
Weight * Little need for long-term follow-up
loss * Can expect to lose at least 65% of
excess body weight
Malnutrition * Minimal malnutrition risk
* Requires 1 MVI daily
Revision * Easy to convert to or add duodenal
switch later
* May allow for increased efficacy of
orlistat and phentermine
Possible * Delayed gastric emptying and reflux
late
compli-
cations
Biliopancreatic diversion with duo-
denal switch and vertical gas-
troplasty/sleeve gastrectomy
Features * Large 90-mL to 150-mL
(ie, 500 tubular stomach
cm un- * Partially restrictive
stretched * Mostly malabsorption
total bowel * May reduce acid reflux but
length) not nonacid reflux
* Works for sweeters, grazers,
and bloaters
* Can be beat with excess
eating of sweets or fat and
overeating
* Wide open anastomosis
* 150-cm Roux limb
* 250-cm biliopancreatic limb
* 100-cm common channel
* Antral, pyloric, and duodenal
preservation
* Stomach segment resected
and removed from body
Weight * High weight loss success
loss * Can expect to lose 70%
to 75% of excess body
weight in first year
* Can expect to lose 85%
to 90% of excess body
weight in second and
third years
* Low failure rate with good
long-term follow-up
Malnutrition * 5% to 7% malnutrition and
vitamin deficiency risk, espe-
cially vitamins A, D, E, and
K and calcium
Revision * Revision may be needed to
treat malnutrition
Possible * Some bowel obstruction risk
late * Volvulus
compli- * Foul smelling stools and gas
cations * Increased diarrhea, fre-
quency, and urgency
Adjustable gastric band
Features * Micropouch
(ie, 500 * Purely restrictive
cm un- * Progressive slow compres-
stretched sion to prevent hunger
total bowel * No stomach stapling
length) * Can fail with sweets,
shakes, and liquids
* Port placed on abdominal
wall
Weight Variable
loss
Malnutrition * Low malnutrition risk
* Requires 1 MVI daily
Revision * Simple low-risk procedure
* Reversible
Possible * Erosion
late * Slippage
compli- * Mega-esophagus
cations
Table 6
POSTOPERATIVE ORDERS FOR LAPAROSCOPIC GASTRIC BYPASS PROCEDURES (1)
Day of surgery
* Activity: help patient out of bed and
into bedside chair twice before bed-time;
no straining or heavy lifting
* Diet: nothing passed orally
* IV: 5% dextrose in .5% normal
saline (NS) with 20 mEq
potassium chloride at 125 mL/hr
* Medications:
** Check blood sugar every (q) 6
hrs, then administer subcutaneous
(SQ) humulin regular
insulin using the sliding scale
Blood sugar Dose
180-200 2 units SQ
201-250 4 units SQ
251-300 6 units SQ
301-350 8 units SQ
351-400 10 units SQ
401-450 10 units SQ and
5 units IV then
recheck blood
sugar after 3 hrs
> 450 Same and call
physician
** Cefotetan 2 g IV piggyback
(IVPB) q 12 hrs for three postoperative
doses, if not allergic
** Famotidine 20 mg IVPB q 8 hrs
for three-postoperative doses
** Patient-controlled analgesia per
anesthesia care providers; discontinue
(D/C) on postoperative
day two and switch to fentanyl
patch 50 mcg/hr
** Enoxaparin 40 mg SQ two times
per day (bid) starting late tonight
** Promethazine 25mg IV push
(IVP) q 4 hrs PRN for nausea
** Acetaminophen 100 mg suppository
per rectum (PR) q 4 hrs
PRN for headache or temperature
> 101[degrees]F (38.3[degrees]C)
** Diphenhydramine 25 mg IVP
q 6 hrs PRN for itching or
insomnia
* Oxygen at 2 L per nasal canula
while awake; continuous positive
airway pressure when sleeping
* Albuterol 0.5 mL in 3 mL NS q 4
hrs and add intermittent positive-pressure
breathing at 10 if poor
effort identified
* Bilateral lower extremity sequential
compression devices (SCDs) over
thromboemboletic stockings
* Vital signs per routine
Postoperative day one
* Activity: as tolerated; no straining
or heavy lifting
* Diet:
** Call resident for diet when upper
gastrointestinal series results
have been received
** Advance diet to full liquids then
to low carbohydrate (ie, diabetic)
clear liquid diet; patient may
dilute juices 50/50
* IV: D/C when diet started
* Laboratory tests: complete blood
count, chemistry profile, chest
x-ray, electrocardiagram, and pulse
oximetry
* Medications: crush all medications
to a powder or open capsules, then
administer in sherbet
** Ursodiol 300 mg taken by mouth
(PO) bid if patient has not had a
cholecystectomy
** Fentanyl patch 25 mcg per hr
PRN for pain
** Acetaminophen/oxycodone one
to two tablets q 4 to 6 hours
PRN for pain if fentanyl patch is
not adequate
** lanoprasole 30 mg PO q day
** Acetaminophen 1,000 mg liquid
PO q 4 hrs PRN for headache or
temperature > 101[degrees]F (38.3 C) if
tolerating oral intake
** D/C meperidine
* Bilateral lower extremity SCDs over
thromboemboletic stockings
** Remove SCDs when patient is
ambulating
** Replace SCDs when patient is
lying in bed or sifting in chair
* Discharge patient to home
** Ensure patient is tolerating oral
medications and liquids
** Provide patient with male urinal
or female toilet hat for at home
monitoring of urine output
* Provide prescriptions for
** Fentanyl patch 25 mcg per hr
PRN for pain
** Acetaminophen/oxycodone 1 to
2 tablets q 4 to 6 hrs PRN for
pain if fentanyl patch is not
adequate
** lanoprasole 30 mg PO q day
** Ursodiol 300 mg PO bid
** Promethazine 25 mg PR q 4 hrs
PRN for nausea
NOTES
(1.) H A Elariny, "Postoperative instructions after open and
laparoscopic gastric bypass," Advanced Laparoscopic and General
Surgery Associates, http://www.alagsa.com/GBP_Instr.htm
(accessed 30 Jan 2003).
NOTES
(1.) A H Mokdad et al, "The spread of the obesity epidemic in the United States, 1991-1998," JAMA 282 (Oct 27, 1999) 1519-1522.
(2.) Ibid.
(3.) M M Ellison, H E Mulcahy, "Obesity: Weighing up the cardiovascular risks" British Journal of Cardiology 8. (February 2001) 61-64.
(4.) "Rationale for the surgical treatment of morbid obesity," American Society for Bariatric Surgery, http://www.asbs.org/html /ration.html (accessed 30 Jan 2003).
(5.) "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults," National Institutes of Health, http://www.nhlbi.nih.gov/guide lines/obesity/ob_home.htm (accessed 30 Jan 2003).
(6.) G S Cowan, Jr, "A predicted future for bariatric surgery: Using the surgical model," Obesity Surgery 6 (February 1996) 12-16; S Abu-Abeid, A Keidar, A Szold, "Resolution of chronic medical conditions after laparoscopic adjustable silicone gastric banding for the treatment of morbid obesity in the elderly," Surgical Endoscopy 15 (February 2001) 132-134; M Deitel, "Surgery for morbid obesity. Overview" European Journal of Gastroenterology and Hepatology 11 (February 1999) 57-61; A M Glenny et al, "The treatment and prevention of obesity: A systematic review of the literature," International Journal of Obesity and Related Metabolic Disorders 21 (September 1997) 715-737.
(7.) A M Macgregor, "The patient factor," Obesity Surgery 6 (August 1996) 325-329.
(8.) "Obesity epidemic puts millions at risk from related diseases: Press release 12 June 1997," World Health Organization, http://www .who.int/archives/inf-pr1997/en/pr97 -46.html (accessed 30 Jan 2003).
(9.) Ibid.
(10.) S J Pavlovich-Danis, "Bariatric surgery update," The Nursing Spectrum 11 (September 2001) 14-17.
Paula Graling, RN, MSN, CNOR, CNS, is the clinical nurse specialist for perioperative services at Inova Fairfax Hospital, Falls Church, Va.
Hazem Elariny, MD, PhD, is a surgeon for Advanced Laparoscopic and General Surgery Associates, Arlington, Va.
Examination
PERIOPERATIVE CARE OF THE PATIENT WITH MORBID OBESITY
1. Patients are considered candidates for surgical
treatment of morbid obesity if they previously
failed at medical weight loss attempts and are
currently severely obese (ie, BMI > --) with
one or more associated comorbidities or morbidly
obese (ie, BMI > --) with or without
comorbidities.
a. 30/35
b. 32/38
c. 35/38
d. 35/40
2. Excess caloric intake sources are categorized as
a. bloating, choosing, grazing, and sweeting.
b. binging, gorging, splurging, and stuffing.
c. bloating, distending, gorging, and grazing.
d. binging, choosing, distending, and sweeting.
3. The -- of the stomach has a
thin wall and a great propensity to stretch, so it
should not be used in the formation of a pouch.
a. lesser curvature of the stomach
b. fundus of the stomach
c. esophagogastric junction
d. body of the stomach
4. Which of the following statements best describes
distal gastric bypass?
a. high malnutrition and vitamin deficiency risk
(ie, 10% to 20%)
b. mostly restrictive
c. requires one multiple vitamin injection daily
d. low malnutrition risk
5. Which of the following statements best describes
biliopancreatic diversion with duodenal switch,
vertical gastroplasty/sleeve gastrectomy.
a. port placed on abdominal wall
b. does not change acid reflux, but reduces total
acid producing capacity
c. simple, reversible, low risk procedure
d. antral, pyloric, and duodenal preservation
6. Which of the following statements best describes
adjustable gastric band?
a. high malnutrition and vitamin deficiency risk
(ie, 10% to 20%)
b. anastamotic ulcer or stricture are possible late
complications
c. progressive slow compression to prevent
hunger
d. bowel obstruction is a possible complication
7. Which of the following statements best describes
proximal gastric bypass?
a. causes dumping syndrome
b. micropouch
c. preserves the pylorus, which prevents dumping
syndrome
d. stomach segment resected and removed from
the body
8. Which of the following statements best describes
vertical gastroplasty with sleeve gastrectomy?
a. no stomach removed
b. little need for long-term follow-up
c. small 15-mL to 30-mL pouch
d. requires 12 vitamin tablets daily
9. Which of the following statements best describes
vertical banded gastroplasty?
a. when successful, expect to lose 90% of excessive
body weight
b. mostly malabsorptive
c. esophagitis is a possible late complication
d. large 90-mL to 150-mL tubular stomach
10. All of the following instructions about postoperative
activity are correct except that the patient is
not instructed
a. to be as active as possible, walking up to one
mile per day by the postoperative office visit.
b. to wear an abdominal binder because this
develops a dependence on it rather than
strengthening the abdominal muscles.
c. increase activity gradually; however, he or she
should avoid heavy lifting for three to six
weeks to allow the incisions to heal solidly.
d. return to work one week after surgery if he or
she underwent a laparoscopic procedure.
COPYRIGHT 2003 Association of Operating Room Nurses, Inc.
COPYRIGHT 2003 Gale Group